Integrating Genomic Testing in Gynecologic Care: Breast and Ovarian Cancer” explores the crucial role of genetic testing in the management of these cancers. This session will delve into the latest advancements in genomic profiling, including BRCA1/2 mutation analysis, HRD testing, and other relevant biomarkers. We’ll discuss how these tests inform risk assessment, personalized treatment decisions, and preventive strategies for women with breast and ovarian cancer. Learn how integrating genomic data into clinical practice enhances patient care and improves outcomes.